[1]
“Incidence, Characteristics, and Management of Alpelisib-Associated Rash in Patients With Advanced Breast Cancer”, J of Skin, vol. 4, no. 6, p. s111, Oct. 2020, doi: 10.25251/skin.4.supp.111.